202 related articles for article (PubMed ID: 16837539)
1. 18-Fluorine-labelled 2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography standardised uptake values: a non-invasive biomarker for the risk of metastasis from choroidal melanoma.
Finger PT; Chin K; Iacob CE
Br J Ophthalmol; 2006 Oct; 90(10):1263-6. PubMed ID: 16837539
[TBL] [Abstract][Full Text] [Related]
2. The relationship between combined positron emission tomography/computed tomography and clinical and light microscopic findings in choroidal melanoma.
Faia LJ; Pulido JS; Donaldson MJ; Salomão DR; Cameron JD; Mullan B; Gunduz K
Retina; 2008 May; 28(5):763-9. PubMed ID: 18463523
[TBL] [Abstract][Full Text] [Related]
3. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
4. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
[TBL] [Abstract][Full Text] [Related]
5. PET/CT imaging: detection of choroidal melanoma.
Reddy S; Kurli M; Tena LB; Finger PT
Br J Ophthalmol; 2005 Oct; 89(10):1265-9. PubMed ID: 16170113
[TBL] [Abstract][Full Text] [Related]
6. Association of high metabolic activity measured by positron emission tomography imaging with poor prognosis of choroidal melanoma.
Lee CS; Cho A; Lee KS; Lee SC
Br J Ophthalmol; 2011 Nov; 95(11):1588-91. PubMed ID: 21317424
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological correlation for the role of fluorodeoxyglucose positron emission tomography computed tomography in detection of choroidal malignant melanoma.
Matsuo T; Ogino Y; Ichimura K; Tanaka T; Kaji M
Int J Clin Oncol; 2014 Apr; 19(2):230-9. PubMed ID: 23456141
[TBL] [Abstract][Full Text] [Related]
8. Association of positive dual-modality positron emission tomography/computed tomography imaging of primary choroidal melanoma with chromosome 3 loss and tumor size.
McCannel TA; Reddy S; Burgess BL; Auerbach M
Retina; 2010 Jan; 30(1):146-51. PubMed ID: 20010323
[TBL] [Abstract][Full Text] [Related]
9. 18FDG-PET/CT assessing the absence of cell viability and excluding metastatic disease in a case of necrotic choroidal melanoma.
Romero-Aroca P; Montero-Jaime M; Intriago B; Riu F; Peña-Gonzalez KB; Almena-Garcia M
Eur J Ophthalmol; 2012; 22(2):288-92. PubMed ID: 21725939
[TBL] [Abstract][Full Text] [Related]
10. Whole body PET/CT for initial staging of choroidal melanoma.
Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC
Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.
Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM
Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771
[TBL] [Abstract][Full Text] [Related]
12. Utility of the PET-CT scan with (18)F-FDG in a case of choroid melanoma recurrence.
Sabate M; García JR; Valls E; Moragas M; Soler M; Riera E; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):167-8. PubMed ID: 22177294
[No Abstract] [Full Text] [Related]
13. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
14. Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients.
Freton A; Chin KJ; Raut R; Tena LB; Kivelä T; Finger PT
Eur J Ophthalmol; 2012; 22(2):236-43. PubMed ID: 21959680
[TBL] [Abstract][Full Text] [Related]
15. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
[TBL] [Abstract][Full Text] [Related]
16. Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
Chin K; Finger PT; Kurli M; Tena LB; Reddy S
Optometry; 2007 Aug; 78(8):396-401. PubMed ID: 17662928
[TBL] [Abstract][Full Text] [Related]
17. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
[TBL] [Abstract][Full Text] [Related]
18. Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.
Kurli M; Chin K; Finger PT
Br J Ophthalmol; 2008 Apr; 92(4):479-82. PubMed ID: 18369064
[TBL] [Abstract][Full Text] [Related]
19. A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features.
Calcagni ML; Mattoli MV; Blasi MA; Petrone G; Sammarco MG; Indovina L; Mulè A; Rufini V; Giordano A
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1682-91. PubMed ID: 23824464
[TBL] [Abstract][Full Text] [Related]
20. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma.
Wen JC; Sai V; Straatsma BR; McCannel TA
JAMA Ophthalmol; 2013 Jan; 131(1):56-61. PubMed ID: 23307209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
